CompletedPhase 2NCT00292695

A Phase II Study of Nasal NK/T-cell Lymphoma

Studying Extranodal nasal NK/T cell lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Health Research Institutes, Taiwan
Principal Investigator
Ming-Chih Chang, M.D.
Lymphoma Disease Committee of Taiwan Cooperative Oncology Group
Intervention
VP-16, Cisplatin, Ifosfamide, Dexamethosone, Mesna, IF-RT(other)
Enrollment
33 target
Eligibility
70 years · All sexes
Timeline
2006 – 2010

Study locations (1)

Collaborators

Mackay Memorial Hospital · National Cheng-Kung University Hospital · Taichung Veterans General Hospital · Taipei Veterans General Hospital, Taiwan · Kaohsiung Veterans General Hospital. · National Taiwan University Hospital · Tri-Service General Hospital · Chi Mei Medical Hospital · Kaohsiung Medical University · Changhua Christian Hospital · Buddhist Tzu Chi General Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00292695 on ClinicalTrials.gov

Other trials for Extranodal nasal NK/T cell lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Extranodal nasal NK/T cell lymphoma →

← Back to all trials